The absence of a developmental phenotype, the observation that Apold1 is activated under ischemic and pro-angiogenic conditions, and the fact that its expression is restricted to vascular endothelial cells could make it an interesting target for future therapeutic interventions to either enhance vascular repair or to restrict tumor vascularization. This evidence concerns the gene APOLD1 and neoplasm.